Paper28940010
Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.
Horváth B and 8 others. Naunyn Schmiedebergs Arch Pharmacol, 2017. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes. Papers, record 28940010. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28940010
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Frequency-dependent effects of omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myocytes, Cardiac | Major topic |
| Urea | Major topic |
| Action Potentials | |
| Animals | |
| Calcium Signaling | |
| Cell Size | |
| Diastole | |
| Dogs | |
| Female | |
| Heart Ventricles | |
| Male | |
| Myocardial Contraction | |
| Myosins | |
| Systole |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| K115397 | National Research Development and Innovation Office | PubMed | ||
| K109736 | National Research Development and Innovation Office | PubMed | ||
| K101196 | National Research Development and Innovation Office | PubMed | ||
| GINOP-2.3.2.-15-2016-00040 | European Union and European Regional Development Fund | PubMed |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23250339 | Effects of tacrolimus on action potential configuration and transmembrane ion currents in canine ventricular cells. | Naunyn Schmiedebergs Arch Pharmacol | 2013 | https://conductscience.org/library/papers/23250339 | PubMed |
| 2 | 26709596 | Relative bioavailability, food effect, and safety of the single-dose pharmacokinetics of omecamtiv mecarbil following administration of different modified-release formulations in healthy subjects. | Int J Clin Pharmacol Ther | 2016 | https://conductscience.org/library/papers/26709596 | PubMed |
| 3 | 27012405 | Acute Treatment With Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: The ATOMIC-AHF Study. | J Am Coll Cardiol | 2016 | https://conductscience.org/library/papers/27012405 | PubMed |
| 4 | 21856480 | Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study. | Lancet | 2011 | https://conductscience.org/library/papers/21856480 | PubMed |
| 5 | 26140433 | The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat. | Br J Pharmacol | 2015 | https://conductscience.org/library/papers/26140433 | PubMed |
| 6 | 25344201 | 9-Anthracene carboxylic acid is more suitable than DIDS for characterization of calcium-activated chloride current during canine ventricular action potential. | Naunyn Schmiedebergs Arch Pharmacol | 2015 | https://conductscience.org/library/papers/25344201 | PubMed |
| 7 | 21187335 | Mouse intact cardiac myocyte mechanics: cross-bridge and titin-based stress in unactivated cells. | J Gen Physiol | 2011 | https://conductscience.org/library/papers/21187335 | PubMed |
| 8 | 27779469 | Dose-dependent electrophysiological effects of the myosin activator omecamtiv mecarbil in canine ventricular cardiomyocytes. | J Physiol Pharmacol | 2016 | https://conductscience.org/library/papers/27779469 | PubMed |
| 9 | 20498236 | Improvement of cardiac function by a cardiac Myosin activator in conscious dogs with systolic heart failure. | Circ Heart Fail | 2010 | https://conductscience.org/library/papers/20498236 | PubMed |
| 10 | 21856481 | The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial. | Lancet | 2011 | https://conductscience.org/library/papers/21856481 | PubMed |
| 11 | 27914656 | Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial. | Lancet | 2016 | https://conductscience.org/library/papers/27914656 | PubMed |
| 12 | 15338108 | Effects of norfluoxetine on the action potential and transmembrane ion currents in canine ventricular cardiomyocytes. | Naunyn Schmiedebergs Arch Pharmacol | 2004 | https://conductscience.org/library/papers/15338108 | PubMed |
| 13 | 8766913 | Action potential duration and force-frequency relationship in isolated rabbit, guinea pig and rat cardiac muscle. | J Comp Physiol B | 1996 | https://conductscience.org/library/papers/8766913 | PubMed |
| 14 | 26065842 | Omecamtiv Mecarbil, a Cardiac Myosin Activator, Increases Ca2+ Sensitivity in Myofilaments With a Dilated Cardiomyopathy Mutant Tropomyosin E54K. | J Cardiovasc Pharmacol | 2015 | https://conductscience.org/library/papers/26065842 | PubMed |
| 15 | 15721865 | Apico-basal inhomogeneity in distribution of ion channels in canine and human ventricular myocardium. | Cardiovasc Res | 2005 | https://conductscience.org/library/papers/15721865 | PubMed |
| 16 | 15952036 | Asymmetrical distribution of ion channels in canine and human left-ventricular wall: epicardium versus midmyocardium. | Pflugers Arch | 2005 | https://conductscience.org/library/papers/15952036 | PubMed |
| 17 | 24566722 | Asynchronous activation of calcium and potassium currents by isoproterenol in canine ventricular myocytes. | Naunyn Schmiedebergs Arch Pharmacol | 2014 | https://conductscience.org/library/papers/24566722 | PubMed |
| 18 | 28082673 | Omecamtiv Mecarbil Enhances the Duty Ratio of Human β-Cardiac Myosin Resulting in Increased Calcium Sensitivity and Slowed Force Development in Cardiac Muscle. | J Biol Chem | 2017 | https://conductscience.org/library/papers/28082673 | PubMed |
| 19 | 20668839 | Effects of ropinirole on action potential characteristics and the underlying ion currents in canine ventricular myocytes. | Naunyn Schmiedebergs Arch Pharmacol | 2010 | https://conductscience.org/library/papers/20668839 | PubMed |
| 20 | 25716967 | Changes in intracellular calcium concentration influence beat-to-beat variability of action potential duration in canine ventricular myocytes. | J Physiol Pharmacol | 2015 | https://conductscience.org/library/papers/25716967 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40911791 | Danicamtiv increases cardiac mechanical efficiency. | J Physiol | 2025 | https://conductscience.org/library/papers/40911791 | PubMed |
| 40831223 | Insights from electromechanical simulations to assess omecamtiv mecarbil efficacy in heart failure. | J Physiol | 2026 | https://conductscience.org/library/papers/40831223 | PubMed |
| 40531056 | Comparative mechanistic analysis of danicamtiv and omecamtiv mecarbil's in vivo cardiac effects. | J Gen Physiol | 2025 | https://conductscience.org/library/papers/40531056 | PubMed |
| 38566963 | Omecamtiv Mecarbil in the treatment of heart failure: the past, the present, and the future. | Front Cardiovasc Med | 2024 | https://conductscience.org/library/papers/38566963 | PubMed |
| 37239022 | Characterization of Stimulatory Action on Voltage-Gated Na+ Currents Caused by Omecamtiv Mecarbil, Known to Be a Myosin Activator. | Biomedicines | 2023 | https://conductscience.org/library/papers/37239022 | PubMed |
| 36986459 | Drug Candidate BGP-15 Prevents Isoproterenol-Induced Arrhythmias and Alters Heart Rate Variability (HRV) in Telemetry-Implanted Rats. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/36986459 | PubMed |
| 36722665 | Omecamtiv mecarbil augments cardiomyocyte contractile activity both at resting and systolic Ca2+ levels. | ESC Heart Fail | 2023 | https://conductscience.org/library/papers/36722665 | PubMed |
| 36613900 | The Novel Cardiac Myosin Activator Danicamtiv Improves Cardiac Systolic Function at the Expense of Diastolic Dysfunction In Vitro and In Vivo: Implications for Clinical Applications. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36613900 | PubMed |
| 36498977 | Antiarrhythmic and Inotropic Effects of Selective Na+/Ca2+ Exchanger Inhibition: What Can We Learn from the Pharmacological Studies? | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36498977 | PubMed |
| 35784869 | Effects of Sarcolemmal Background Ca2+ Entry and Sarcoplasmic Ca2+ Leak Currents on Electrophysiology and Ca2+ Transients in Human Ventricular Cardiomyocytes: A Computational Comparison. | Front Physiol | 2022 | https://conductscience.org/library/papers/35784869 | PubMed |
| 35229734 | Myosin modulators: emerging approaches for the treatment of cardiomyopathies and heart failure. | J Clin Invest | 2022 | https://conductscience.org/library/papers/35229734 | PubMed |
| 34832924 | Late Na+ Current Is [Ca2+]i-Dependent in Canine Ventricular Myocytes. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34832924 | PubMed |
| 34716531 | Generative adversarial networks for construction of virtual populations of mechanistic models: simulations to study Omecamtiv Mecarbil action. | J Pharmacokinet Pharmacodyn | 2022 | https://conductscience.org/library/papers/34716531 | PubMed |
| 34404848 | The development of L-type Ca2+ current mediated alternans does not depend on the restitution slope in canine ventricular myocardium. | Sci Rep | 2021 | https://conductscience.org/library/papers/34404848 | PubMed |
| 33929079 | Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (-)-noradrenaline. | Pharmacol Res Perspect | 2021 | https://conductscience.org/library/papers/33929079 | PubMed |
| 33844095 | Omecamtiv mecarbil evokes diastolic dysfunction and leads to periodic electromechanical alternans. | Basic Res Cardiol | 2021 | https://conductscience.org/library/papers/33844095 | PubMed |
| 32969560 | Effects of omecamtiv mecarbil on calcium-transients and contractility in a translational canine myocyte model. | Pharmacol Res Perspect | 2020 | https://conductscience.org/library/papers/32969560 | PubMed |
| 31999537 | The Control of Diastolic Calcium in the Heart: Basic Mechanisms and Functional Implications. | Circ Res | 2020 | https://conductscience.org/library/papers/31999537 | PubMed |
| 31956082 | Force and Calcium Transients Analysis in Human Engineered Heart Tissues Reveals Positive Force-Frequency Relation at Physiological Frequency. | Stem Cell Reports | 2020 | https://conductscience.org/library/papers/31956082 | PubMed |
| 31541103 | Simultaneous measurement of excitation-contraction coupling parameters identifies mechanisms underlying contractile responses of hiPSC-derived cardiomyocytes. | Nat Commun | 2019 | https://conductscience.org/library/papers/31541103 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MYH14 | 79784 | PubTator's text mining | https://conductscience.org/library/genes/79784 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28940010
GET https://conductscience.org/api/papers/v1/28940010/references?page=2